Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,243,000 | 18,263,000 | 15,301,000 | 9,514,000 | 5,085,000 |
| Depreciation Amortization | 1,512,000 | 5,838,000 | 3,372,000 | 2,218,000 | 1,099,000 |
| Income taxes - deferred | -315,000 | -1,671,000 | -846,000 | -634,000 | -186,000 |
| Accounts receivable | N/A | -1,090,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 110,000 | N/A | N/A | N/A |
| Other Working Capital | -1,613,000 | -6,976,000 | -4,657,000 | -5,971,000 | -3,712,000 |
| Other Operating Activity | 8,577,000 | 1,998,000 | 445,000 | 666,000 | 214,000 |
| Operating Cash Flow | $3,918,000 | $16,472,000 | $13,615,000 | $5,793,000 | $2,500,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -374,000 | 471,000 | 425,000 | -150,000 | -139,000 |
| PPE Investments | -991,000 | -4,112,000 | -3,079,000 | -2,092,000 | -1,328,000 |
| Net Acquisitions | -8,779,000 | -10,042,000 | N/A | N/A | N/A |
| Other Investing Activity | -66,000 | -58,000 | 114,000 | -15,000 | -20,000 |
| Investing Cash Flow | $-10,210,000 | $-13,741,000 | $-2,540,000 | $-2,257,000 | $-1,487,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,061,000 | N/A | 63,000 | 48,000 | N/A |
| Debt Issued | N/A | 13,880,000 | 5,962,000 | N/A | N/A |
| Debt Repayment | -1,140,000 | -2,503,000 | -2,501,000 | -2,500,000 | -2,500,000 |
| Common Stock Issued | 157,000 | 92,000 | 45,000 | 31,000 | 19,000 |
| Common Stock Repurchased | -874,000 | -5,084,000 | -3,832,000 | -2,509,000 | -1,164,000 |
| Dividend Paid | -2,105,000 | -8,176,000 | -6,158,000 | -4,127,000 | -2,050,000 |
| Other Financing Activity | -80,000 | -131,000 | -252,000 | -254,000 | -60,000 |
| Financing Cash Flow | $-2,981,000 | $-1,922,000 | $-6,673,000 | $-9,311,000 | $-5,755,000 |
| Exchange Rate Effect | -19,000 | 563,000 | 540,000 | 530,000 | 156,000 |
| Beginning Cash Position | 14,690,000 | 13,318,000 | 13,318,000 | 13,318,000 | 13,318,000 |
| End Cash Position | 5,398,000 | 14,690,000 | 18,260,000 | 8,073,000 | 8,732,000 |
| Net Cash Flow | $-9,292,000 | $1,372,000 | $4,942,000 | $-5,245,000 | $-4,586,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,918,000 | 16,472,000 | 13,615,000 | 5,793,000 | 2,500,000 |
| Capital Expenditure | -991,000 | -4,112,000 | -3,079,000 | -2,092,000 | -1,328,000 |
| Free Cash Flow | 2,927,000 | 12,360,000 | 10,536,000 | 3,701,000 | 1,172,000 |